For CD8+ TILs, intratumoral CD8+, CD8+ TILsTC, was significantly higher in tumors with the well differentiation (OR, 0.228; 95% CI [0.066–0.782]) and without lymph node metastasis (OR, 0.347; 95% CI [0.138–0.871]). The gene discussed is CD8A; the disease is metastatic malignant neoplasm in the lymph nodes.